Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 17, 2000

View Archived Issues

Interaction regulating apoptosis could impact cancer therapy development

NF-kappaB implicated in mechanism underlying cachexia

Immtech begins DB-289 human trials for opportunistic infection

D-Pharm's neuroprotective drug candidate nears phase II

Anxiolytic-like effects described for nafadotride in animal model

NPS-1506: a summary of data up to early clinical trials in stroke patients

Preclinical and clinical experience with BMS-204352, a maxi-K channel opener, discussed at EFNS

Tempol exerts short- and long-term protective effects in stroke model

Effects of repeated doses of YF-476 on gastric pH examined in healthy volunteers

Successful treatment of breakthrough pain with intranasal morphine

Sonus refocuses development strategy towards drug delivery, blood substitutes

Clinical trials of new RSV therapeutic VP-14637 commence

FDA approves Novantrone for worsening forms of multiple sclerosis

Extended-release Lescol XL cleared by FDA for cholesterol reduction

Abbott researchers design novel water-soluble K+ channel openers

New agents for diabetes and related conditions emerge from joint research conducted at Japanese labs

Kyorin patents new AMPA receptor antagonists and their use

Novel antiinflammatory/immunomodulatory agents identified at Kowa

Aventis presents several related series of anorectic compounds

Preparation and use of new TK inhibitors as antiangiogenic agents

NIH grant awarded to Novasite to develop technology

Amgen to acquire Kinetix

Intellivax's nasal proteosome flu vaccine enters phase I

Enzyme replacement therapy for MPS VI proceeds to phase I/II

EGF receptor-related research collaboration with M.D. Anderson announced by Enchira

Cholera vaccine moves into phase IIb trials

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...